These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1890137)

  • 1. Investigation into the immunological effects of miltefosine, a new anticancer agent under development.
    Hilgard P; Kampherm E; Nolan L; Pohl J; Reissmann T
    J Cancer Res Clin Oncol; 1991; 117(5):403-8. PubMed ID: 1890137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic effects of alkylphosphocholines or alkylphosphocholine-liposomes and macrophages on tumor cells.
    Zeisig R; Jungmann S; Fichtner I; Daemen T; Arndt D
    Anticancer Res; 1994; 14(5A):1785-9. PubMed ID: 7847811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Miltefosine enhances phagocytosis but decreases nitric oxide production by peritoneal macrophages of C57BL/6 mice.
    Ponte CB; Alves EA; Sampaio RN; Urdapilleta AA; Kückelhaus Cdos S; Muniz-Junqueira MI; Kückelhaus SA
    Int Immunopharmacol; 2012 May; 13(1):114-9. PubMed ID: 22465961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lead induced modulation of splenic macrophage responses on humoral and cell mediated immunity.
    Bishayi B; Sengupta M; Ghosh S
    Acta Microbiol Immunol Hung; 2004; 51(1-2):31-45. PubMed ID: 15362286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sea cucumber (Codonopsis pilosula) oligopeptides: immunomodulatory effects based on stimulating Th cells, cytokine secretion and antibody production.
    He LX; Zhang ZF; Sun B; Chen QH; Liu R; Ren JW; Wang JB; Li Y
    Food Funct; 2016 Feb; 7(2):1208-16. PubMed ID: 26838796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells.
    Kearney R; Basten A; Nelson DS
    Int J Cancer; 1975 Mar; 15(3):438-50. PubMed ID: 1079792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miltefosine decreases the cytotoxic effect of epirubicine and cyclophosphamide on mouse spermatogenic, thymic and bone marrow cells.
    Martinova Y; Topashka-Ancheva M; Konstantinov S; Petkova S; Karaivanova M; Berger M
    Arch Toxicol; 2006 Jan; 80(1):27-33. PubMed ID: 16079990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
    Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
    Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulation and antitumor activity of kappa-carrageenan oligosaccharides.
    Yuan H; Song J; Li X; Li N; Dai J
    Cancer Lett; 2006 Nov; 243(2):228-34. PubMed ID: 16410037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin augments protective immune responses in murine macrophages and enhances potential of miltefosine against experimental visceral leishmaniasis.
    Shivahare R; Ali W; Vishwakarma P; Natu SM; Puri SK; Gupta S
    Acta Trop; 2015 Oct; 150():35-41. PubMed ID: 26119043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A possible mechanism of tumor regression in cisplatin-treated mice.
    Sarna S; Sodhi A; Bhola RK
    Pol J Pharmacol Pharm; 1989; 41(1):69-76. PubMed ID: 2587438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative analysis of the immunopharmacological properties of three new nitrosourea analogues: RPCNU, RFCNU and Chlorozotocin.
    Florentin I; Hayat M; Kiger N; Mathé G; Maral J; Imbach JL
    Int J Immunopharmacol; 1983; 5(3):201-10. PubMed ID: 6225736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumor and immunomodulatory activity of iron hepta-tungsten phosphate oxygen clusters complex.
    Zhang B; Qiu J; Wu C; Li Y; Liu Z
    Int Immunopharmacol; 2015 Dec; 29(2):293-301. PubMed ID: 26590115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory and antitumor activity of triterpenoid fractions from the rhizomes of Astilbe chinensis.
    Tu J; Sun HX; Ye YP
    J Ethnopharmacol; 2008 Sep; 119(2):266-71. PubMed ID: 18692123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological response modifying effect of chemotherapeutic agents against cancer].
    Ogura T
    Gan To Kagaku Ryoho; 1984 May; 11(5):965-73. PubMed ID: 6232899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of cytotoxic spleen cells and effects of serum factors in a syngeneic rat tumour system.
    Matthews N; Chalmers PJ; Flannery GR; Nairn RC
    Br J Cancer; 1976 Mar; 33(3):279-89. PubMed ID: 773397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limited immunotoxic potential of technical formulation of the herbicide atrazine (AAtrex) in mice.
    Fournier M; Friborg J; Girard D; Mansour S; Krzystyniak K
    Toxicol Lett; 1992 May; 60(3):263-74. PubMed ID: 1534425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by selected anticancer agents of the development of primary cell-mediated immunity against allogeneic tumor cells in culture.
    Orsini F; Eppolito C; Ehrke MJ; Mihich E
    Cancer Treat Rep; 1980; 64(2-3):211-8. PubMed ID: 6967756
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of some cephalosporins on immunological response.
    Borowski J; Jakoniuk P; Talarczyk J
    Drugs Exp Clin Res; 1985; 11(2):83-8. PubMed ID: 3915284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory activity of biopolymeric fraction RLJ-NE-205 from Picrorhiza kurroa.
    Gupta A; Khajuria A; Singh J; Bedi KL; Satti NK; Dutt P; Suri KA; Suri OP; Qazi GN
    Int Immunopharmacol; 2006 Oct; 6(10):1543-9. PubMed ID: 16919826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.